TICAM2 and cancer: According to the KEGG analysis, CHST11 may participate in PD‐L1 expression and PD‐1 checkpoint pathway in cancer by regulating genes TICAM2, LAT, TLR2, CD4, STAT3, NFKBIE and CD3D.